Sigyn Therapeutics
(OTC) SIGY
Sigyn Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$5.77K
Net Income (TTM)
$3.22M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SIGY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sigyn Therapeutics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
4
CEO
James A. Joyce
Website
www.sigyntherapeutics.comHeadquarters
San Diego, CA 92106, US
SIGY Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
-326%
Net Income Margin
-558%
Return on Equity
62%
Return on Capital
49%
Return on Assets
-24%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.61K
Operating Income
$2.52M
EBITDA
$2.52M
Operating Cash Flow
$872.44K
Capital Expenditure
$0.00
Free Cash Flow
$872.44K
Cash & ST Invst.
$12.14K
Total Debt
$2.19M
Sigyn Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
4
N/A
Net Income
$578.50K
+51.7%
EBITDA
$576.48K
+30.7%
Quarterly Fundamentals
Net Cash
$2.73M
-54.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
-100.0%
Long Term Debt
$2.06M
+2660.3%
Short Term Debt
$750.86K
-59.6%
Return on Assets
-23.76%
N/A
Return on Invested Capital
48.78%
N/A
Free Cash Flow
$199.33K
-21.7%
Operating Cash Flow
$199.33K
-21.7%